Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Carcinoma, Ovarian Epithelial × Topotecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Small Cell Lung Carcinoma 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

mirvetuximab soravtansine 2 Paclitaxel 2 sacituzumab govitecan 1 pembrolizumab 1 liposomal doxorubicin 1 Topotecan 1 Saline Solution 1 Glucose 1 Docetaxel 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04209855 2025-08-27

MIRASOL

AbbVie

Phase 3 Completed

453 enrolled 18 charts 1 FDA

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡